IPG grabs $10M for device implant cost-management system

IPG pulled in a $10 million Series C to help fuel development and growth of its software designed, in part, to help manage device implant use and spending. Camden Partners led the round, along with participation from existing investor Sequoia Capital. IPG's platform generates data regarding the overall cost and quality of implant procedures. Execs frame the concept as a novel way to help control costs by linking insurers, providers, hospitals and device makers. IPG, based in Alpharetta, GA, has raised $50 million to date. Item

Suggested Articles

J&J launched a virtual clinical study to gauge whether Apple’s iPhone and ECG-enabled smartwatch can help reduce the risk of stroke and catch AFib.

The Salt Lake City-based developer said its Logix Smart test is now available to be exported from Utah to countries requiring the CE Mark.

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.